InsidersTradesSigma
Track the 제테마 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 제테마 has published 121 insider filings. Market capitalisation: €155bn. The latest transaction was filed on 3 July 2026 (Purchase). Among the most active insiders: 박종우. All data is openly available.
121
Insider Decl.
n/a
Thresholds
€277,791
27 ops.
Buy Volume
€4m
15 ops.
Sell Volume
23Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,114 of 28,685 companies
24.4
score / 100
Value22
Quality27
FCF yld-2.5%
Earn yld-3.5%
EV/EBITDA26.7x
ROE-8.2%
Gross mgn48%
Net mgn-8.6%
Debt/EBITDA10.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 July 2026
Declarations121 total
25 of 121 declarations
关于 제테마
제테마 是一家在 XKRX 市场上市的健康和制药领域的公司。它专注于药品的开发和商业化。